Literature DB >> 12672888

Is there an ethical difference between preimplantation genetic diagnosis and abortion?

C Cameron1, R Williamson.   

Abstract

When a person at risk of having a child with a genetic illness or disease wishes to have an unaffected child, this can involve difficult choices. If the pregnancy is established by sexual intercourse, the fetus can be tested early in pregnancy, and if affected a decision can be made to abort in the hope that a future pregnancy with an unaffected fetus ensures. Alternatively, preimplantation genetic diagnosis (PGD) can be used after in vitro fertilisation (IVF) to select and implant an unaffected embryo that hopefully will proceed to term and produce a healthy baby. We are aware that many individuals at risk regard the latter as ethically more acceptable than the former, and examine whether there is an ethical difference between these options. We conclude that PGD and implantation of an unaffected embryo is a more acceptable choice ethically than prenatal diagnosis (PND) followed by abortion for the following reasons: Choice after PGD is seen as ethically neutral because a positive result ("a healthy pregnancy") balances a negative result ("the destruction of the affected embryo") simultaneously (assuming the pregnancy proceeds to full term and a healthy baby is born). While there is usually the intention to establish a healthy pregnancy after an abortion, this is not simultaneous; A woman sees abortion as a personal physical violation of her integrity, and as the pregnancy proceeds she increasingly identifies with and gives ethical status to the embryo/fetus as it develops in utero and not in the laboratory; Many people see aborting a fetus as "killing", whereas in the case of PGD the spare embryos are "allowed to die". We argue that this difference of opinion gives further weight to our conclusion, but note that this has been addressed and debated at length by others.

Entities:  

Keywords:  Genetics and Reproduction

Mesh:

Year:  2003        PMID: 12672888      PMCID: PMC1733710          DOI: 10.1136/jme.29.2.90

Source DB:  PubMed          Journal:  J Med Ethics        ISSN: 0306-6800            Impact factor:   2.903


  3 in total

1.  Active and passive euthanasia.

Authors:  J Rachels
Journal:  N Engl J Med       Date:  1975-01-09       Impact factor: 91.245

2.  Preimplantation diagnosis or chorionic villus biopsy? Women's attitudes and preferences.

Authors:  Z Miedzybrodzka; A Templeton; J Dean; N Haites; J Mollison; N Smith
Journal:  Hum Reprod       Date:  1993-12       Impact factor: 6.918

3.  Procreative beneficence: why we should select the best children.

Authors:  J Savulescu
Journal:  Bioethics       Date:  2001-10       Impact factor: 1.898

  3 in total
  10 in total

1.  The new Italian law on assisted reproduction technology (Law 40/2004).

Authors:  V Fineschi; M Neri; E Turillazzi
Journal:  J Med Ethics       Date:  2005-09       Impact factor: 2.903

2.  Attitudes to reproductive genetic testing in women who had a positive BRCA test before having children: a qualitative analysis.

Authors:  Elizabeth Ormondroyd; Louise Donnelly; Clare Moynihan; Cornelie Savona; Elizabeth Bancroft; D Gareth Evans; Rosalind Eeles; Stuart Lavery; Maggie Watson
Journal:  Eur J Hum Genet       Date:  2011-08-03       Impact factor: 4.246

3.  Breast cancer, BRCA mutations, and attitudes regarding pregnancy and preimplantation genetic diagnosis.

Authors:  Ashley H Woodson; Kimberly I Muse; Heather Lin; Michelle Jackson; Danielle N Mattair; Leslie Schover; Terri Woodard; Laurie McKenzie; Richard L Theriault; Gabriel N Hortobágyi; Banu Arun; Susan K Peterson; Jessica Profato; Jennifer K Litton
Journal:  Oncologist       Date:  2014-06-20

4.  The Perfect Womb: Promoting Equality of (Fetal) Opportunity.

Authors:  Evie Kendal
Journal:  J Bioeth Inq       Date:  2017-02-21       Impact factor: 1.352

5.  The decision-making process of genetically at-risk couples considering preimplantation genetic diagnosis: initial findings from a grounded theory study.

Authors:  Patricia E Hershberger; Agatha M Gallo; Karen Kavanaugh; Ellen Olshansky; Alan Schwartz; Ilan Tur-Kaspa
Journal:  Soc Sci Med       Date:  2012-03-07       Impact factor: 4.634

6.  Acceptable applications of preimplantation genetic diagnosis (PGD) among Israeli PGD users.

Authors:  Shachar Zuckerman; David A Zeevi; Sigal Gooldin; Gheona Altarescu
Journal:  Eur J Hum Genet       Date:  2017-07-26       Impact factor: 4.246

Review 7.  Conceptualizing couples' decision making in PGD: emerging cognitive, emotional, and moral dimensions.

Authors:  Patricia E Hershberger; Penny F Pierce
Journal:  Patient Educ Couns       Date:  2010-01-08

Review 8.  Controlling Sickle Cell Disease in Ghana--ethics and options.

Authors:  Ama Kyerewaa Edwin; Frank Edwin; Victor Etwire
Journal:  Pan Afr Med J       Date:  2011-10-03

Review 9.  Potential use of clinical polygenic risk scores in psychiatry - ethical implications and communicating high polygenic risk.

Authors:  A C Palk; S Dalvie; J de Vries; A R Martin; D J Stein
Journal:  Philos Ethics Humanit Med       Date:  2019-02-27       Impact factor: 2.464

10.  Some ethical issues in the prenatal diagnosis of sickle cell anaemia.

Authors:  Joseph O Fadare
Journal:  Ann Ib Postgrad Med       Date:  2009-12
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.